01 — Financials
Financial overview
Revenue
NOK 7,543,191
Period ending 2024-12-31
Operating profit
NOK 7,433,834
Profit before tax
NOK 6,717,834
Net profit
NOK 6,717,834
Total assets
NOK 48,966,324
Equity
NOK 48,966,324
Latest reporting period ending 2024-12-31
02 — Signals & news
Recent activity
No signals tracked yet
Funding rounds, hiring activity, and leadership changes will appear here when detected
Set up alerts for this company
Get notified about funding, hiring, and leadership changes
03 — Get in touch
Reach VIVI IRENE HANSENS FOND TIL FORSKNING AV SYKDOMMEN LUPUS ERYTHEMATOSUS DISSEMINATUS STI
Key people
Leif Sven Pedersen
Styre
Einar Lie
Styre
Stine Marie Ulven
Styre
Benedicte Elisabeth Agerup
Styre
Anders Malthe-Sørenssen
Styre
Draft an intro emailpro
AI-generated contextual outreach
Prepare a meeting briefpro
One-page summary for your next call
Find decision-makerspro
Search by role and seniority
04 — Similar companies
Companies like VIVI IRENE HANSENS FOND TIL FORSKNING AV SYKDOMMEN LUPUS ERYTHEMATOSUS DISSEMINATUS STI
Similar company matching coming soon
We're building AI-powered matching based on industry, size, location, and business model
Discover companies in our directory
Search >100,000 Nordic companies by name, industry, or location
Get the full picture on VIVI IRENE HANSENS FOND TIL FORSKNING AV SYKDOMMEN LUPUS ERYTHEMATOSUS DISSEMINATUS STI
Financial history, alerts, outreach tools, and more. Free to use within limits.
Sign up free